FDA Approves Prolensa For Pain, Inflammation After Cataract Surgery

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Monday, April 8, 2013

Ocular Surgery News

The U.S. Food and Drug Administration approved Bausch + Lomb’s new drug application for bromfenac ophthalmic solution, according to a company news release.

Full Story

What is the treatment for stage I DLK?
1. Steroids
2. Lifting and irrigating under the flap
3. MMC
4. PTK
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
CareCloud Central
CareCloud Central is a medical practice ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

FDA Approves Prolensa For Pain, Inflammation After Cataract Surgery

Comments

Quick Quiz

What is the treatment for stage I DLK?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

CareCloud Central

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2